WeChatshare
Synthetic Biology Carnival 2023

You can share it to WeChat via the Qr code.

Eventsshare
Synthetic Biology Carnival 2023

Enter the applet sharing event using WeChat scan.

Details

Synthetic biology is the world's third biotechnology revolution, following the discovery of the DNA double helix and the Human Genome Project. The last two enable people to interpretate lives rather than simply recognize them. Synthetic biology has witnessed the transition from life interpretation to its authoring and creation, upending life science in the 21st century.


Similarly, industrialization of synthetic biology has already occurred. Industrialization results in breakthroughs inquantity, quality, and expenditures, spawning new markets such as health food and medical beauty. On the other hand, the original industrial pattern, which was dominated by traditional high energy and high pollution processes, is being innovated as a result of industrialization's low cost, high quality, and environmental claim.


The 2023 Synthetic Biology Carnival (SBC2023), co-organized by the Chinese Society for Microbiology, Shandong University, State Key Laboratory of Microbial Technology, Shandong University, "Innovation China" Biomedical Industry Technology Service Group and BioValley will be held on April 21-22 in Nanjing, Jiangsu Province. This carnival will focus on the application of frontier synthetic biotechnology, the rise of new forces, industry policy guidance, and future trends in an effort to promote the coordinated.


Conference Introduction


Time:April 21-22, 2023

Theme: SynBio New Force & Future

Place: Hilton Nanjing Langsheng Hotel

Size: Over 800 participants

Guider: Nanjing Jiangbei New District Management Committee

Sponsors:"Innovation China" Biomedical Industry Technology Service Group; Chinese Society for Microbiology; Shandong University; East China University of Science and Technology;State Key Laboratory of Microbial Technology, Shandong University; Biomatrix, BioValley - a community pooling biomedical knowledge

Supporters:National Center of Bio-Engineering & Technology (Shanghai), East China University of Science and Technology; Beijing Advanced Innovation Center for Soft Matter Science and Engineering; Key Laboratory of Synthetic Biology, Chinese Academy of Sciences; Shanghai Society for Microbiology; Shanghai Society for Biotechnology; Chinese Biopharmaceutical Association (CBA); Nanjing Society of Biomedical Engineering

Strategic Media Partners: Transformants, Bio-creat


Three Highlights

合成官网-英文版.png



Participants


参会类型.png

Presidium

主席团.png

Framework

论坛框架.jpg

Agenda
2023-04-21
2023-04-22
2023-04-21
09:00 -12:20
Main Conference

Host:Zhuang Yingping,Director of National Engineering Research Center for  Biotechnology (Shanghai); Former Dean of School of Bioengineering, East China  University of Science and Technology  

Guo Meijin,Professor and Doctoral Supervisor of State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology

2023-04-21
09:00-09:05

Host Opening

2023-04-21
09:05-09:10

Speech from Host

Xiang Hua, Secretary-general of Chinese Society for Microbiology, Deputy Director-General of the Institute of  Microbiology, Chinese Academy of Sciences 

Wu Hui, Secretary of Party Committee, College of Biological Engineering, East China University of Science  and Technology

2023-04-21
09:10-09:50

Biological Manufacturing and Future Manufacturing

Ying Hanjie, Academician of the Chinese Academy of Engineering, Director of National Biochemical  Engineering Technology Research Center, Professor of Nanjing Tech University

2023-04-21
09:50-10:30

Formulation of POD Class Anti-tumor New Drugs

Tang Yajie, Professor of Shandong University, National Outstanding Youth

2023-04-21
10:30-11:00

Tea break

2023-04-21
11:00-11:40

Synthetic Biology and LBP Development

Ye Bangce, Dean of the School of Biotechnology at East China University of Science and Technology

2023-04-21
11:40-12:20

Panel: Opportunities and Challenges in the Development and Industrial Application of Synthetic Biology

Host:

Fang Baishan, Founding Director of the Key Laboratory of Synthetic Biology of Xiamen, Professor of Xiamen  University 


Panelists: 

Zhuang Yingping, Director of National Engineering Research Center for Biotechnology (Shanghai), Former  Dean of School of Bioengineering, East China University of Science and Technology  

Zhang Haoqian, Co-founder and CEO of Bluepha 

Gao Hang, Managing Partner of Venture Capital Fund of MengNiu 

Ye Haifeng, Researcher and Associate Dean of East China Normal University 

Li Xiangyu, CEO of CABIO

2023-04-21
13:30 -17:00
Forum I: Synthetic Biology Key Technology and Tool Application

Host: Wu Hui, Secretary of Party Committee, College of Biological Engineering, East China University of Science and Technology

2023-04-21
13:30-14:00

Synthetic Biology Driven by Industry 4.0: From Lab to Fab

Zhang Haoqian, Co-founder and CEO of Bluepha

2023-04-21
14:00-14:30

ZCloud - A Comprehensive Ecological Synthetic Bioparts Computational Design  Platform

Wang Sheng, CEO of ZELIXIR BIOTECH

2023-04-21
14:30-15:00

Automation Platform Empowers Synthetic Biology

Song Jiali, Product Manager of Molecular Devices

2023-04-21
15:00-15:30

Tea break

2023-04-21
15:30-16:00

Twist Bioscience Composes the Future of Synthetic Biology

Guan Jianping, Field Application Scientist of Twist Bioscience

2023-04-21
16:00-16:30

Design and Process Development of Commercial Production and Fermentation  System for Biological Synthesis

Wang Limeng, Senior Technical Manager of Pharmac

2023-04-21
16:30-17:00

Cloud Creates All Things - The Evolution of Synthetic Biology in the Cloud-based  Intelligent Era

Li Jian, Chief Medical Offiffifficer of Great China, Amazon Web Services

2023-04-21
13:30 -17:00
Forum II: Synthetic Biomedicine and Health

Host:Ye Haifeng, Researcher and Associate Dean of East China Normal University

2023-04-21
13:30-14:00

Engineering Living Biological Drugs: A New Therapy Driven by Synthetic Biology

Chen Jingyu, CEO of U-SynBio

2023-04-21
14:00-14:30

Intelligent Living Drugs Based on Artifificial Gene Circuits

Ye Haifeng, Researcher and Associate Dean of East China Normal University

2023-04-21
14:30-15:00

Production of Pharmaceutical Chemicals through Synthetic Biology

Yuan Qipeng, Director of Beijing Advanced Innovation Center for Soft Matter Science and Engineering

2023-04-21
15:00-15:30

Tea break

2023-04-21
15:30-16:00

Construction and Application of Organoid Model in Synthetic Biology

Huang Weiren, Researcher of the First Affiffiffiliated Hospital of Shenzhen University

2023-04-21
16:00-16:30

Application of a Novel Base Editing Technology

Xu Tianhong, Founder of Base Therapeutics

2023-04-21
16:30-17:00

Biosynthetic Corneas Based on Recombinant Human Collagen

Zhang Jinzhong, Chairman and CEO of Eluminex Biosciences

2023-04-21
13:30 -17:30
Forum III: Synthetic Biology Application

Host:Chen Lu, Associate Dean of Huaheng Biotechnology Research Institute

2023-04-21
13:30-14:00

Application of Synthetic Biology in the Industrialization of the Cosmetics Sector

Yang Shengping, Chief Scientist of Huiwen Biotech

2023-04-21
14:00-14:30

Exploration of the Core Elements of Synthetic Biology Manufacturing

Chen Lu, Associate Dean of Huaheng Biotechnology Research Institute

2023-04-21
14:30-15:00

From Synthetic Biology to Large-scale Bio-manufacturing: Bottlenecks and  Prospects for Breakthroughs

Wang Yuheng, Chief Engineer of Synthetic Biology Industrialization Center, Tianjushi Engineering Technology Group

2023-04-21
15:00-15:30

Tea break

2023-04-21
15:30-16:00

Synthetic Biology and AI Technology Drive the Bio-manufacturing of New Molecules - Recombinant Mussel Adhesive Protein

Cui Junfeng, Co-founder and CEO of PAM2LBiotechnologies

2023-04-21
16:00-16:30

Synthesis and Application of γ-glutamyl Peptides by Enzymatic Method

Cui Chun, Professor of South China University of Technology; Director Guangdong Engineering Technology  Research Center of Special Enzymes

2023-04-21
16:30-17:00

Application and Market Prospects of Polylactic Acid

Shao Yunpeng, Deputy General Manager of Hanggai Biological

2023-04-21
17:00-17:30

Straw Substrate Biosynthesis - Necessity, Feasibility and Practice of a 10,000-ton  Production Line

Wang Zhongchang,Technical Director of YIWEISEN

2023-04-22
09:00 -17:00
Forum I: Synthetic Biology Key Technology and Tool Application

Host of April 22 AM:Ye Bangce, Dean of the School of Biotechnology at East China University  of Science and Technology

Host of April 22 PM:Xu Jian, Professor and Director of Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences

2023-04-22
09:00-09:30

Synthetic Biology: Past, Present and Future

Zhao Guoping, Academician of the Chinese Academy of Sciences, Molecular microbiologist

2023-04-22
09:30-10:00

Low-Carbon Biosynthesis: From Pathway Breakthroughs to Process Development

Liu Jianming, Researcher of Westlake University

2023-04-22
10:00-10:30

Tea break

2023-04-22
10:30-11:00

How to Meet the Growth Microenvironmental Requirements of Various Microorganisms and Cells

Liang Lang, Deputy General Manager of Andgel Industrial

2023-04-22
11:00-11:30

DNA Bio-synthesis Technology

Jiang Huifeng, Researcher of Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences

2023-04-22
11:30-12:00

Production of Bulk Fatty Acid Synthetic Biology with Non-food Biomass

Yang Shihui, Professor of Hubei University

2023-04-22
13:30-14:00

How Enzymes Become Powerful Synthesis Tools

Chen Haibin, Co-founder of Enzymaster

2023-04-22
14:00-14:30

Key Technologies and Applications of Synthetic Biology

Shi Shuobo, Professor of Beijing University of Chemical Technology

2023-04-22
14:30-15:00

Flow-mode Raman-activated Cell Sorter (FlowRACS): A new tool for label-free,  metabolic-function-based and high-throughput mining of cell factories and  enzymes

Xu Jian, Professor and Director of Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese  Academy of Sciences

2023-04-22
15:00-15:30

Tea break

2023-04-22
15:30-16:00

Industrialization Progress of Fungal Protein

Han Wang, Co-founder and CEO of MoreMeat

2023-04-22
16:00-16:30

Synthetic Biology Study of Plant Natural Compounds

Zhou Zhihua, Researcher of CAS-Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular  Plant Sciences, Chinese Academy of Sciences

2023-04-22
16:30-17:00

Research on the Construction of Digital Cell Models and Intelligent Design of  Strain in the Big Data Era

Lu Hongzhong, Associate Tenure-Track Professor of Shanghai Jiao Tong University

2023-04-22
09:00 -17:00
Forum II: Synthetic Biomedicine and Health

Host of April 22 AM:Han Chao,CIO of Joincare Biopharm Research Institute

Host of April 22 PM:Dai Lei,Researcher of Shenzhen Institute of Advanced Technology,Chinese  Academy of Sciences


2023-04-22
09:00-09:30

How Synthetic Biology Empowers the Development of Biological Medicine

Lin Qiubin, Founder and CEO of Delonix

2023-04-22
09:30-10:00

Advancing Innovative RNAi Therapeutics for Cancer Treatment

Lu Yang,Founder, Chairman of the Board and CEO of Sirnaomics

2023-04-22
10:00-10:30

Tea break

2023-04-22
10:30-11:00

Gene Editing for, of, and as Immunotherapy

Chen Sidi, Associate Professor of Yale University

2023-04-22
11:00-11:30

Industrial High-yield Filamentous Fungus Created by Using Synthetic Biology

Han Chao, CIO of Joincare Biopharm Research Institute

2023-04-22
11:30-12:00

Synthetic Immunology New Technology Based on Tumor Antigen Recognition

Hu Shi, Research Associate of Naval Medical University

2023-04-22
13:30-14:00

Synthesis and Application of Medical Functional Polymers and Monomer Resources

Zou Xiang, Professor of the College of Pharmaceutical Sciences of Southwest University

2023-04-22
14:00-14:30

Application of mRNA-enhanced Stem Cell Therapy in Regenerative Medicine

Wang Gang, Founder and Chairman of GeneHeal Medicine

2023-04-22
14:30-15:00

Global Landscape & Progress of NextGen Microbiome Therapeutics

Jiang Xianzhi, Founder and CEO of MoonBiotech

2023-04-22
15:00-15:30

Tea break

2023-04-22
15:30-16:00

Microbiome Engineering

Dai Lei, Researcher of Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences

2023-04-22
16:00-16:30

Development of Gene Therapy Drugs Using Bacterial Vectors

Xiang Bin, Founder of CommBio Therapeutics

2023-04-22
16:30-17:00

Biosynthesis of High Value Added Natural Products and Drugs

Wang Xiao, CEO of SYNBIOLAB

2023-04-22
09:00 -17:00
Forum III: Synthetic Biology Application

Host of April 22 AM:Ding Shijie, CEO of Joes Future Food

Host of April 22 PM:Miao Xuexia, Chairman and Chief Scientist of Plant Science Biotechnology

2023-04-22
09:00-09:30

Leading Industrial Development with Synthetic Biology that Creates Everything

Li Xiangyu, CEO of CABIO

2023-04-22
09:30-10:00

Development and Progress of Core Technology for Cell-cultured Meat

Ding Shijie, CEO of Joes Future Food

2023-04-22
10:00-10:30

Tea break

2023-04-22
10:30-11:00

The Applications of Computational Modelling of Gene Expression

Tamir Tuller, CSO of Imagindairy

2023-04-22
11:00-11:30

Innovative Applications of Synthetic Biology in the Sustainable Economy of  Desert Ecosystems

Wang Zhongchang, Technical Director of YIWEISEN

2023-04-22
11:30-12:00

Synthetic Biology-coupled Precision Fermentation to Produce Milk Bioactive  Proteins

Shou Wong, Chief Innovation Officer of Turtletree

2023-04-22
13:30-14:00

Opportunities and Challenges in the Development of Biosynthetic Nitrogen  Fixation

Cao Yi, CTO of GreeN Bio

2023-04-22
14:00-14:30

Application of RNAi Bio-pesticides in Crop Protection

Miao Xuexia, Chairman and Chief Scientist of Plant Science Biotechnology

2023-04-22
14:30-15:00

Intelligent Fermentation Equipment and Industrial Digitialization

Hao Yuyou, Chairman of Manson Biotechnology

2023-04-22
15:00-15:30

Tea break

2023-04-22
15:30-16:00

Development and Application of Precise Gene Editing Technology

Kevin Zhao, CTO of Qiheshengke Biotechnology

2023-04-22
16:00-16:30

Discussion on the Current Situation - Domestic and International Progress of the  Recombinant Collagen Industry

Li Haihang, Chief Technology Offiffifficer of Trautec

2023-04-22
16:30-17:00

Industrial Application of Synthetic Biology

Lin Tao, Founder of Enzymetree

Host Opening

Speech from Host

Biological Manufacturing and Future Manufacturing

Formulation of POD Class Anti-tumor New Drugs

Tea break

Synthetic Biology and LBP Development

Panel: Opportunities and Challenges in the Development and Industrial Application of Synthetic Biology

Synthetic Biology Driven by Industry 4.0: From Lab to Fab

ZCloud - A Comprehensive Ecological Synthetic Bioparts Computational Design  Platform

Automation Platform Empowers Synthetic Biology

Tea break

Twist Bioscience Composes the Future of Synthetic Biology

Design and Process Development of Commercial Production and Fermentation  System for Biological Synthesis

Cloud Creates All Things - The Evolution of Synthetic Biology in the Cloud-based  Intelligent Era

Engineering Living Biological Drugs: A New Therapy Driven by Synthetic Biology

Intelligent Living Drugs Based on Artifificial Gene Circuits

Production of Pharmaceutical Chemicals through Synthetic Biology

Tea break

Construction and Application of Organoid Model in Synthetic Biology

Application of a Novel Base Editing Technology

Biosynthetic Corneas Based on Recombinant Human Collagen

Application of Synthetic Biology in the Industrialization of the Cosmetics Sector

Exploration of the Core Elements of Synthetic Biology Manufacturing

From Synthetic Biology to Large-scale Bio-manufacturing: Bottlenecks and  Prospects for Breakthroughs

Tea break

Synthetic Biology and AI Technology Drive the Bio-manufacturing of New Molecules - Recombinant Mussel Adhesive Protein

Synthesis and Application of γ-glutamyl Peptides by Enzymatic Method

Application and Market Prospects of Polylactic Acid

Straw Substrate Biosynthesis - Necessity, Feasibility and Practice of a 10,000-ton  Production Line

Synthetic Biology: Past, Present and Future

Low-Carbon Biosynthesis: From Pathway Breakthroughs to Process Development

Tea break

How to Meet the Growth Microenvironmental Requirements of Various Microorganisms and Cells

DNA Bio-synthesis Technology

Production of Bulk Fatty Acid Synthetic Biology with Non-food Biomass

How Enzymes Become Powerful Synthesis Tools

Key Technologies and Applications of Synthetic Biology

Flow-mode Raman-activated Cell Sorter (FlowRACS): A new tool for label-free,  metabolic-function-based and high-throughput mining of cell factories and  enzymes

Tea break

Industrialization Progress of Fungal Protein

Synthetic Biology Study of Plant Natural Compounds

Research on the Construction of Digital Cell Models and Intelligent Design of  Strain in the Big Data Era

How Synthetic Biology Empowers the Development of Biological Medicine

Advancing Innovative RNAi Therapeutics for Cancer Treatment

Tea break

Gene Editing for, of, and as Immunotherapy

Industrial High-yield Filamentous Fungus Created by Using Synthetic Biology

Synthetic Immunology New Technology Based on Tumor Antigen Recognition

Synthesis and Application of Medical Functional Polymers and Monomer Resources

Application of mRNA-enhanced Stem Cell Therapy in Regenerative Medicine

Global Landscape & Progress of NextGen Microbiome Therapeutics

Tea break

Microbiome Engineering

Development of Gene Therapy Drugs Using Bacterial Vectors

Biosynthesis of High Value Added Natural Products and Drugs

Leading Industrial Development with Synthetic Biology that Creates Everything

Development and Progress of Core Technology for Cell-cultured Meat

Tea break

The Applications of Computational Modelling of Gene Expression

Innovative Applications of Synthetic Biology in the Sustainable Economy of  Desert Ecosystems

Synthetic Biology-coupled Precision Fermentation to Produce Milk Bioactive  Proteins

Opportunities and Challenges in the Development of Biosynthetic Nitrogen  Fixation

Application of RNAi Bio-pesticides in Crop Protection

Intelligent Fermentation Equipment and Industrial Digitialization

Tea break

Development and Application of Precise Gene Editing Technology

Discussion on the Current Situation - Domestic and International Progress of the  Recombinant Collagen Industry

Industrial Application of Synthetic Biology

Speakers
  • Academician of the Chinese Academy of Sciences, Molecular microbiologistZhao Guoping
    Zhao Guoping
    Academician of the Chinese Academy of Sciences, Molecular microbiologist
  • Professor of Shandong University, National Outstanding YouthTang Yajie
    Tang Yajie
    Professor of Shandong University, National Outstanding Youth
  • Director of National Engineering Research Center for  Biotechnology (Shanghai); Former Dean of School of Bioengineering, East China  University of Science and TechnologyZhuang Yingping
    Zhuang Yingping
    Director of National Engineering Research Center for Biotechnology (Shanghai); Former Dean of School of Bioengineering, East China University of Science and Technology
  • Director of Beijing Advanced Innovation Center for Soft Matter Science and EngineeringYuan Qipeng
    Yuan Qipeng
    Director of Beijing Advanced Innovation Center for Soft Matter Science and Engineering
  • Professor and Doctoral Supervisor of State Key Laboratory of Bioreactor Engineering, East China University of Science and TechnologyGuo Meijin
    Guo Meijin
    Professor and Doctoral Supervisor of State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology
  • Academician of the Chinese Academy of Engineering, Director of National Biochemical  Engineering Technology Research Center, Professor of Nanjing Tech UniversityYing Hanjie
    Ying Hanjie
    Academician of the Chinese Academy of Engineering, Director of National Biochemical Engineering Technology Research Center, Professor of Nanjing Tech University
  • Secretary-general of Chinese Society for Microbiology, Deputy Director-General of the Institute of  Microbiology, Chinese Academy of SciencesXiang Hua
    Xiang Hua
    Secretary-general of Chinese Society for Microbiology, Deputy Director-General of the Institute of Microbiology, Chinese Academy of Sciences
  • Secretary of Party Committee, College of Biological Engineering, East China University of Science  and TechnologyWu Hui
    Wu Hui
    Secretary of Party Committee, College of Biological Engineering, East China University of Science and Technology
  • Dean of the School of Biotechnology at East China University of Science and TechnologyYe Bangce
    Ye Bangce
    Dean of the School of Biotechnology at East China University of Science and Technology
  • Associate Dean of Huaheng Biotechnology Research InstituteChen Lu
    Chen Lu
    Associate Dean of Huaheng Biotechnology Research Institute
  • Co-founder of EnzymasterChen Haibin
    Chen Haibin
    Co-founder of Enzymaster
  • CEO of CABIOLi Xiangyu
    Li Xiangyu
    CEO of CABIO
  • Co-founder and CEO of BluephaZhang Haoqian
    Zhang Haoqian
    Co-founder and CEO of Bluepha
  • Managing Partner of Venture Capital Fund of MengNiuGao Hang
    Gao Hang
    Managing Partner of Venture Capital Fund of MengNiu
  • CIO of Joincare Biopharm Research InstituteHan Chao
    Han Chao
    CIO of Joincare Biopharm Research Institute
  • Chief Medical Officer of Great China, Amazon Web ServicesLi Jian
    Li Jian
    Chief Medical Officer of Great China, Amazon Web Services
  • Chairman and Chief Scientist of Plant Science BiotechnologyMiao Xuexia
    Miao Xuexia
    Chairman and Chief Scientist of Plant Science Biotechnology
  • CTO of GreeN BioCao Yi
    Cao Yi
    CTO of GreeN Bio
  • CEO of Joes Future FoodDing Shijie
    Ding Shijie
    CEO of Joes Future Food
  • CEO of ZELIXIR BIOTECHWang Sheng
    Wang Sheng
    CEO of ZELIXIR BIOTECH
  • Co-founder and CEO of PAM2LBiotechnologiesCui Junfeng
    Cui Junfeng
    Co-founder and CEO of PAM2LBiotechnologies
  • Researcher and Associate Dean of East China Normal UniversityYe Haifeng
    Ye Haifeng
    Researcher and Associate Dean of East China Normal University
  • Researcher of Tianjin Institute of Industrial Biotechnology, Chinese Academy of SciencesJiang Huifeng
    Jiang Huifeng
    Researcher of Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences
  • Founder and Chairman of GeneHeal MedicineWang Gang
    Wang Gang
    Founder and Chairman of GeneHeal Medicine
  • Founder and CEO of DelonixLin Qiubin
    Lin Qiubin
    Founder and CEO of Delonix
  • Research Associate of Naval Medical UniversityHu Shi
    Hu Shi
    Research Associate of Naval Medical University
  • Chairman and CEO of Eluminex BiosciencesZhang Jinzhong
    Zhang Jinzhong
    Chairman and CEO of Eluminex Biosciences
  • Founder, Chairman of the Board and CEO of SirnaomicsLu Yang
    Lu Yang
    Founder, Chairman of the Board and CEO of Sirnaomics
  • Chief Engineer of Synthetic Biology Industrialization Center, Tianjushi Engineering Technology GroupWang Yuheng
    Wang Yuheng
    Chief Engineer of Synthetic Biology Industrialization Center, Tianjushi Engineering Technology Group
  • CTO of Qiheshengke BiotechnologyKevin Zhao
    Kevin Zhao
    CTO of Qiheshengke Biotechnology
  • Professor of South China University of Technology; Director Guangdong Engineering Technology  Research Center of Special EnzymesCui Chun
    Cui Chun
    Professor of South China University of Technology; Director Guangdong Engineering Technology Research Center of Special Enzymes
  • Deputy General Manager of Hanggai BiologicalShao Yunpeng
    Shao Yunpeng
    Deputy General Manager of Hanggai Biological
  • Chief Technology Officer of TrautecLi Haihang
    Li Haihang
    Chief Technology Officer of Trautec
  • Professor of Beijing University of Chemical TechnologyShi Shuobo
    Shi Shuobo
    Professor of Beijing University of Chemical Technology
  • Founder of EnzymetreeLin Tao
    Lin Tao
    Founder of Enzymetree
  • Professor of Hubei UniversityYang Shihui
    Yang Shihui
    Professor of Hubei University
  • Founder of Base TherapeuticsXu Tianhong
    Xu Tianhong
    Founder of Base Therapeutics
  • Technical Director of YIWEISENWang Zhongchang
    Wang Zhongchang
    Technical Director of YIWEISEN
  • Researcher of the First Affiliated Hospital of Shenzhen UniversityHuang Weiren
    Huang Weiren
    Researcher of the First Affiliated Hospital of Shenzhen University
  • Researcher of Shenzhen Institute of Advanced Technology, Chinese Academy of SciencesDai Lei
    Dai Lei
    Researcher of Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences
  • Founder of CommBio TherapeuticsXiang Bin
    Xiang Bin
    Founder of CommBio Therapeutics
  • Associate Professor of Yale UniversityChen Sidi
    Chen Sidi
    Associate Professor of Yale University
  • Senior Technical Manager of PharmacWang Limeng
    Wang Limeng
    Senior Technical Manager of Pharmac
  • CSO of ImagindairyTamir Tuller
    Tamir Tuller
    CSO of Imagindairy
  • Chief Innovation Officer of TurtletreeShou Wong
    Shou Wong
    Chief Innovation Officer of Turtletree
  • Founding Director of the Key Laboratory of Synthetic Biology of Xiamen, Professor of Xiamen  UniversityFang Baishan
    Fang Baishan
    Founding Director of the Key Laboratory of Synthetic Biology of Xiamen, Professor of Xiamen University
  • Product Manager of Molecular DevicesSong Jiali
    Song Jiali
    Product Manager of Molecular Devices
  • Researcher of CAS-Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular  Plant Sciences, Chinese Academy of SciencesZhou Zhihua
    Zhou Zhihua
    Researcher of CAS-Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences
  • Chief Scientist of Huiwen BiotechYang Shengping
    Yang Shengping
    Chief Scientist of Huiwen Biotech
  • Chairman of Manson BiotechnologyHao Yuyou
    Hao Yuyou
    Chairman of Manson Biotechnology
  • Professor and Director of Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese  Academy of SciencesXu Jian
    Xu Jian
    Professor and Director of Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences
  • CEO of U-SynBioChen Jingyu
    Chen Jingyu
    CEO of U-SynBio
  • Deputy General Manager of Andgel IndustrialLiang Lang
    Liang Lang
    Deputy General Manager of Andgel Industrial
  • Associate Tenure-Track Professor of Shanghai Jiao Tong UniversityLu Hongzhong
    Lu Hongzhong
    Associate Tenure-Track Professor of Shanghai Jiao Tong University
  • Professor of the College of Pharmaceutical Sciences of Southwest UniversityZou Xiang
    Zou Xiang
    Professor of the College of Pharmaceutical Sciences of Southwest University
  • CEO of SYNBIOLABWang Xiao
    Wang Xiao
    CEO of SYNBIOLAB
  • Co-founder and CEO of MoreMeatHan Wang
    Han Wang
    Co-founder and CEO of MoreMeat
  • Founder and CEO of MoonBiotechJiang Xianzhi
    Jiang Xianzhi
    Founder and CEO of MoonBiotech
  • Researcher of Westlake UniversityLiu Jianming
    Liu Jianming
    Researcher of Westlake University
  • Field Application Scientist of Twist BioscienceGuan Jianping
    Guan Jianping
    Field Application Scientist of Twist Bioscience
  • Technical Director of YIWEISENWang Zhongchang
    Wang Zhongchang
    Technical Director of YIWEISEN
  • Featured Activities

    特色活动.png

    Registration
    Preparation Stage
    Registration
    End of Event
    Choose ticket
    Type
    Price(¥)
    Sales End
    Quantity
    Free Ticket
    Free
    2023-04-22 08:30
    Sold Out
    Registration will need approval from the organizer.
    Price
    0
    Contact Us

    The 2023 Synthetic Biology Industry Carnival provides you with cost-effective and customized sponsorship solutions, if you want to have a new product promotion plan in 2023, or if you want to get close to business decision makers, then you must not miss our conference!


    Customized exhibition/academic exchange/registration/media cooperation, please contact:

    Contact: Abby

    Mobile: 18217659261 (same number as WeChat)

    E-mail: xiaolang.jiang@biovalleyclub.com


    Sponsored seats are limited! There are not many star booths! Contact us now!

    Organizational Units

    竖版-彩色.png

    The "Innovation China" Biomedical Industry Technology Service Group, led by the Chinese Society for Microbiology and backed by the Biochemical Process Modeling and Control Professional Committee, works with colleges and universities, research institutes, industry-leading enterprises and application bases to address the development and innovation needs of the microbial industry. Their aim is to sustainably develop biomedical innovation research and talents, thereby accelerating the integrated development of the Beijing-Tianjin-Hebei region, the Yangtze River Economic Belt, the Yangtze River Delta, the rise of central China, and the trailblazing development of eastern China. They will remain deeply involved in the fields of biomedicine, microbial medicine, microbial fermentation technology, and microbial amplification technology, offering specialized services integrating biomedical technology, equipment, consultation, information, training, and education to pharmaceutical enterprises, agricultural pharmaceutical enterprises, and food fermentation enterprises. They will collaborate with schools and businesses to accelerate the integration of theory and practice in microbial strain transformation technology, fermentation optimization technology, scale-up technology, and engineering design, delivering an infinite array of practical talents to the industry.


    1. Main services include: research and development of microbial medicine; production of fermentation products; fermentation engineering design; consulting services for cellular drug, antibody, or vaccine drug preparation technology; industry reporting; workplace education and training services; intellectual property services; project transaction services; solutions for biomedical precision marketing; biomedical investment and financing services.


    2. List of members of the Biochemical Process Modeling and Control Professional Committee

    123.png


    3. Member of the Service Group

    Biochemical Process Modeling and Control Professional Committee, Chinese Society for Microbiology

    School of Bioengineering, East China University of Science and Technology

    Collaborative Innovation Center, Zhejiang University of Technology

    College of Life Sciences, Northwest A&F University

    School of Bioengineering, Jiangnan University

    Angel Yeast Co., Ltd

    Guangdong Vtr Bio-Tech Co., Ltd

    Shell Biotech

    Baiaoyuan (Shanghai) Network Technology Co., Ltd

    Shanghai Xifan Business Consulting Co., Ltd

    Shanghai Jiahua Law Firm


    4. Expert On-site Service Cases (Qilu Pharmaceutical, Bioactive, King-phar Pharmaceutical, Biobase, etc.

    科创11.jpg



    学会logo矢量文件.png


    Founded on December 18, 1952, the Chinese Society for Microbiology joined the International Union of Microbiological Societies (IUMS) in 1980. It has more than 21,000 members and 23 professional committees as well as 6 working committees, covering all branches and fields of microbiology. The Society always upholds the people’s democratic dictatorship, adopts the motto "unity and cooperation, innovation and dedication", and takes an active role in activities such as academic exchanges, international exchanges, scientific popularization, talent recommendation and decision consultation. It has sponsored 7 academic journals, including Acta Microbiologica Sinica, Acta Virologica, Chinese Journal of Zoonoses, Journal of Biological Engineering, Virologica Sinica, Microbiology China and Journal of Microbiology. It established mLife in collaboration with the Institute of Microbiology, CAS. These scholarly publications have contributed in some way to the advancement of this field's academics.


    In response to the demands of national economic construction, scientific research, production, and teaching, the Society has conducted a variety of academic exchanges to energize academic ideas, encourage discipline development, and develop young talents since its inception. It organizes and co-organizes over 30 academic conferences in various formats each year.


    The year 2022 marked the 70th anniversary of the Society. To commemorate this milestone, the Society launched a number of initiatives under the theme "the 70th Anniversary, the Persistent Pursuit of the Humble Way into Distance" in order to "keep up with the world's scientific and technological frontier, race into the economic battlefield, deal with the major national needs, and strive for the people's life and health." To serve the agriculture and biomedical sectors, four "Innovation China" Biomedical Industry Technology Service Groups have been established, with the "Innovation China" biomedicine branch supported by demonstration projects. Four expert decision-making and consultation groups have been formed to improve the Society's ability to pool knowledge and wisdom and better assist the Party and the government in making scientific decisions.


    1672795620808-ckt-抠图.png

    Shandong University is a key comprehensive university under the direct administration of the Ministry of Education, with a distinguished history, a broad spectrum of academic specialties, significant strengths, and distinguishing features. It wields considerable power both at home and abroad. The University was admitted to the list of world top (Class A) universities in 2017. The academic clout and contribution of the university's 18 disciplines have been in the top 1% of ESI world rankings, and 5 disciplines have reached the top 1; disciplines such as microbiology, mechanics, materials science, cardiovascular and cerebrovascular function restoration, new drug manufacturing, and Chinese classical philosophy have all risen to domestic first-class status, with some directions and fields reaching global prominence.

     

    Over the past 120 years, the university has consistently upheld the tenet "Reserve talents for the world, and seek prosperity for the nation," committed the school motto "Noble in Spirit; Boundless in Knowledge," created their school ethos "Respect the truth and seek the new," trained more than 600,000 talents of various kinds, and made significant contributions to national and regional economic and social development.



    佰傲谷logo-彩色透明.png


    BioValley is a biopharma and biotechnology focused knowledge community. BioValley is the leading member of “Innovation China” Biopharma Industry Science & Technology Service Group, led by Chinese Society for Microbiology (CSM) under China Association for Science and Technology (CAST). In the spirit of Focus & Originality, BioValley is committed to providing the high-value knowledge, holistic consulting services, and precision marketing solutions to the entire biopharmaceutical industry.


    BioValley has six new media brands - Biovalley, Biotitude, Immunology Chat, BioV-Test, Bio Frontier, Bio Career Express Bus, with totally 300,000+ subscribers. Over 70% of them are industrial leaders at or above manager levels, including CEOs and entrepreneurs. For these talents, we empower them with the cutting-edge knowledge, specialized training, and career opportunities. For their enterprises, we provide precision marketing and branding solutions, industrial connections, R&D consulting, employee training and recruitment, etc. BioValley has been recognized as a platform with “attitude, altitude, warmth”, a close liaison for all stakeholders on the value chain of this industry.


    Up to now, BioValley has released 2300+ original articles attracting totally 85 million readings and organized 100+ webinars reaching 32,000 audiences. Every year, BioValley organizes several high-level national conferences and industrial exhibitions such as Bio-ONE, QbD, and CGCT. In the future, we are dedicated to continuously empowering the biopharma industry, with the ambition of becoming the leading biopharma knowledge community in China.  

    Sponsors

    赞助商logo.png

    Media Partners

    合作媒体logo.png

    Previous Brand Conferences
    Check E-tickets
    Please enter the ticket recipient's email or cell phone
    Retrieve